Ignite Creation Date:
2025-12-24 @ 1:41 PM
Ignite Modification Date:
2026-01-01 @ 11:31 AM
Study NCT ID:
NCT05482295
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-06
First Post:
2022-07-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
Sponsor:
PT Bio Farma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-29
First Submit QC Date:
None
Study First Post Date:
2022-08-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-03
Last Update Post Date:
2025-06-06
Last Update Post Date Type:
ACTUAL